Actively Recruiting

Phase Not Applicable
Age: 25Years - 85Years
All Genders
NCT06685744

TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial

Led by Fondazione Don Carlo Gnocchi Onlus · Updated on 2025-03-03

300

Participants Needed

6

Research Sites

87 weeks

Total Duration

On this page

Sponsors

F

Fondazione Don Carlo Gnocchi Onlus

Lead Sponsor

F

Fondazione Don Carlo Gnocchi Onlus, IRCCS Milano

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of the FIT4TeleNEURO pragmatic trial is to verify, in real-life care contexts, the superiority in terms of the effectiveness of early rehabilitation intervention with Telerehabilitation (TR) protocols (TR single Approach, task-oriented - TRsA; TR combined approach, task-oriented and impairment-oriented - TRcA) compared to conventional management (Educational treatment, ET). The main questions it aims to answer are: * Are Telerehabilitation protocols more effective than educational treatment? * Is the TRcA treatment more effective than the TRsA? The study investigates the effects of rehabilitation treatment by comparing the two target cases (Multiple Sclerosis - MS and Parkinson's Diseases - PD). Participants will be subjective to: * 3 time-point of assessment (baseline, post-treatment and follow up) with motor, cognitive and quality-of-life measures * A 5-weeks rehabilitation treatment (4 times/week)

CONDITIONS

Official Title

TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial

Who Can Participate

Age: 25Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of probable Parkinson Disease between stages 1 and 3 on the Hoehn & Yahr scale or diagnosis of Multiple Sclerosis with disability level EDSS 64.5
  • Age between 25 and 85 years
  • Cognitive level above 15.5 on the Montreal Cognitive Assessment (MoCA) test
  • Not currently participating in any rehabilitation program
  • Stable drug treatment for at least three months: L-Dopa or dopamine agonists for Parkinson Disease, or Disease Modifying Therapies for Multiple Sclerosis
Not Eligible

You will not qualify if you...

  • Presence of comorbidities preventing safe home rehabilitation or causing clinical instability
  • Major psychiatric complications or personality disorders
  • Severe visual or hearing impairments
  • History of falls causing injury or more than two falls in the six months before enrollment
  • Pregnancy
  • For Multiple Sclerosis: ongoing relapse or relapse within the last three months
  • For Parkinson Disease: frequent freezing with a score of 3 or higher on UPDRS Section II
  • For Multiple Sclerosis: cerebellar function score of 3 or higher on EDSS-FS

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Istituti Clinici Scientifici Maugeri SpA

Bari, Italy, 70124

Actively Recruiting

2

IRCCS Azienda Ospedaliera Universitaria San Martino

Genova, Italy, 16132

Actively Recruiting

3

Centro Riabilitativo Villa Beretta

Lecco, Italy, 23845

Actively Recruiting

4

Fondazione Don Carlo Gnocchi Onlus, IRCCS

Milan, Italy, 20148

Actively Recruiting

5

University of Modena and Reggio Emilia

Modena, Italy, 41121

Actively Recruiting

6

Istituto Neurologico Nazionale IRCCS Casimiro Mondino

Pavia, Italy, 27100

Actively Recruiting

Loading map...

Research Team

F

FRANCESCA BAGLIO, MD FRANCESCA BAGLIO, MD

CONTACT

F

FEDERICA ROSSETTO, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here